SLOW-K Drug Patent Profile
✉ Email this page to a colleague
When do Slow-k patents expire, and what generic alternatives are available?
Slow-k is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in SLOW-K is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Slow-k
A generic version of SLOW-K was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
US Patents and Regulatory Information for SLOW-K
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SLOW-K | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017476-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
